These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 21180468

  • 1. Assessment of asthma and chronic obstructive pulmonary disorder in relation to reversibility, IgE, eosinophil, and neutrophil count in a University Teaching Hospital in South Delhi, India.
    Rathod VP, Kapoor P, Pillai KK, Khanam R.
    J Pharm Bioallied Sci; 2010 Oct; 2(4):337-40. PubMed ID: 21180468
    [Abstract] [Full Text] [Related]

  • 2. Post-bronchodilator Reversibility of FEV1 and Eosinophilic Airway Inflammation in COPD.
    Chou KT, Su KC, Hsiao YH, Huang SF, Ko HK, Tseng CM, Su VY, Perng DW.
    Arch Bronconeumol; 2017 Oct; 53(10):547-553. PubMed ID: 28438346
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of lung volume response with airflow response to bronchodilator in patients with chronic obstructive pulmonary disease].
    Zhang FQ, Zheng JP, Wang JH, Lu WB, Wu RX, Li XS, Xian QZ, Gao Y, Jiang M.
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):109-13. PubMed ID: 20367950
    [Abstract] [Full Text] [Related]

  • 4. Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease.
    Katoh S, Ikeda M, Shirai R, Abe M, Ohue Y, Kobashi Y, Oka M.
    J Asthma; 2018 Oct; 55(10):1052-1058. PubMed ID: 29035604
    [Abstract] [Full Text] [Related]

  • 5. The impact of inflammatory cells on lung function in asthmatics in a cross sectional retrospect study.
    Li Y, Wang J, Zhao Q, Jin F, Liu G, Pan L.
    Heliyon; 2024 Jul 15; 10(13):e33691. PubMed ID: 39071553
    [Abstract] [Full Text] [Related]

  • 6. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF, Zhao M, Li ZL, Song Y, Shi Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar 15; 30(3):192-6. PubMed ID: 17572998
    [Abstract] [Full Text] [Related]

  • 7. Computed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: eotaxin-1 is associated with bronchodilator response and extent of emphysema.
    Miller M, Ramsdell J, Friedman PJ, Cho JY, Renvall M, Broide DH.
    J Allergy Clin Immunol; 2007 Nov 15; 120(5):1118-25. PubMed ID: 17983873
    [Abstract] [Full Text] [Related]

  • 8. [Levels of HMGB1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease].
    Cheng Z, Kang Y, Wu QG, Dai LL, Song YN, Xia J, Si JM, Chen CY.
    Zhonghua Yi Xue Za Zhi; 2011 Nov 15; 91(42):2981-4. PubMed ID: 22333024
    [Abstract] [Full Text] [Related]

  • 9. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P, Guo YF, Sun TY, Zhang HS, Chai D, Li XM.
    Zhonghua Nei Ke Za Zhi; 2016 Sep 01; 55(9):679-83. PubMed ID: 27586974
    [Abstract] [Full Text] [Related]

  • 10. Reversibility to a beta2-agonist in COPD: relationship to atopy and neutrophil activation.
    Sitkauskiene B, Sakalauskas R, Malakauskas K, Lötvall J.
    Respir Med; 2003 Jun 01; 97(6):591-8. PubMed ID: 12814141
    [Abstract] [Full Text] [Related]

  • 11. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
    Ben Saad H, Préfaut C, Tabka Z, Zbidi A, Hayot M.
    Pulm Pharmacol Ther; 2008 Oct 01; 21(5):767-73. PubMed ID: 18555715
    [Abstract] [Full Text] [Related]

  • 12. [A clinical study of serum IgE concentrations in elderly patients with bronchial asthma and chronic obstructive pulmonary disease].
    Motegi T, Kida K.
    Nihon Kokyuki Gakkai Zasshi; 1999 Aug 01; 37(8):608-13. PubMed ID: 10496098
    [Abstract] [Full Text] [Related]

  • 13. Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?
    Cosío BG, Pérez de Llano L, Lopez Viña A, Torrego A, Lopez-Campos JL, Soriano JB, Martinez Moragon E, Izquierdo JL, Bobolea I, Callejas J, Plaza V, Miravitlles M, Soler-Catalunya JJ, on behalf of the CHACOS study group.
    Eur Respir J; 2017 May 01; 49(5):. PubMed ID: 28461299
    [Abstract] [Full Text] [Related]

  • 14. Safety and application of induced sputum analysis in childhood asthma.
    Covar RA, Spahn JD, Martin RJ, Silkoff PE, Sundstrom DA, Murphy J, Szefler SJ.
    J Allergy Clin Immunol; 2004 Sep 01; 114(3):575-82. PubMed ID: 15356559
    [Abstract] [Full Text] [Related]

  • 15. [Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap].
    Yang H, Zhang Y, Zhang J, Pan J, Wang F, Luo X, Chen F.
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep 30; 38(10):1215-1221. PubMed ID: 30377121
    [Abstract] [Full Text] [Related]

  • 16. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma.
    Kostikas K, Gaga M, Papatheodorou G, Karamanis T, Orphanidou D, Loukides S.
    Chest; 2005 May 30; 127(5):1553-9. PubMed ID: 15888827
    [Abstract] [Full Text] [Related]

  • 17. Correlation of total serum immunoglobulin E level, sputum, and peripheral eosinophil count in assessing the clinical severity in bronchial asthma.
    Kumar RM, Pajanivel R, Koteeswaran G, Menon SK, Charles PM.
    Lung India; 2017 May 30; 34(3):256-261. PubMed ID: 28474652
    [Abstract] [Full Text] [Related]

  • 18. Asthma-like Features and Clinical Course of Chronic Obstructive Pulmonary Disease. An Analysis from the Hokkaido COPD Cohort Study.
    Suzuki M, Makita H, Konno S, Shimizu K, Kimura H, Kimura H, Nishimura M, Hokkaido COPD Cohort Study Investigators.
    Am J Respir Crit Care Med; 2016 Dec 01; 194(11):1358-1365. PubMed ID: 27224255
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V, Gálffy G, Orosz M, Kováts Z, Odler B, Selroos O, Tamási L.
    Int J Chron Obstruct Pulmon Dis; 2016 Dec 01; 11():93-101. PubMed ID: 26834466
    [Abstract] [Full Text] [Related]

  • 20. Serum interleukin-1beta as a marker for differentiation of asthma and chronic obstructive pulmonary disease.
    Mahajan B, Vijayan VK, Agarwal MK, Bansal SK.
    Biomarkers; 2008 Nov 01; 13(7):713-27. PubMed ID: 19096964
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.